» Articles » PMID: 19931353

Tumor Heterogeneity: Causes and Consequences

Overview
Specialties Biochemistry
Biophysics
Date 2009 Nov 26
PMID 19931353
Citations 758
Authors
Affiliations
Soon will be listed here.
Abstract

With rare exceptions, spontaneous tumors originate from a single cell. Yet, at the time of clinical diagnosis, the majority of human tumors display startling heterogeneity in many morphological and physiological features, such as expression of cell surface receptors, proliferative and angiogenic potential. To a substantial extent, this heterogeneity might be attributed to morphological and epigenetic plasticity, but there is also strong evidence for the co-existence of genetically divergent tumor cell clones within tumors. In this perspective, we summarize the sources of intra-tumor phenotypic heterogeneity with emphasis on genetic heterogeneity. We review experimental evidence for the existence of both intra-tumor clonal heterogeneity as well as frequent evolutionary divergence between primary tumors and metastatic outgrowths. Furthermore, we discuss potential biological and clinical implications of intra-tumor clonal heterogeneity.

Citing Articles

CV1-secreting sCAR-T cells potentiate the abscopal effect of microwave ablation in heterogeneous tumors.

Cao B, Liu M, Xiao Z, Leng D, Zhou Y, Zhang Z Cell Rep Med. 2025; 6(2):101965.

PMID: 39970874 PMC: 11866491. DOI: 10.1016/j.xcrm.2025.101965.


Single-cell copy number calling and event history reconstruction.

Kuipers J, Tuncel M, Ferreira P, Jahn K, Beerenwinkel N Bioinformatics. 2025; 41(3).

PMID: 39946094 PMC: 11897432. DOI: 10.1093/bioinformatics/btaf072.


Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer.

Wolf I, Schultze-Seemann S, Gratzke C, Wolf P Antibodies (Basel). 2025; 14(1.

PMID: 39846613 PMC: 11755620. DOI: 10.3390/antib14010005.


T-cell Receptor Repertoire Analysis in the Context of Transarterial Chemoembolization Synergy with Systemic Therapy for Hepatocellular Carcinoma.

Li J, Zhang Y, Hu L, Ye H, Yan X, Li X J Clin Transl Hepatol. 2025; 13(1):69-83.

PMID: 39801788 PMC: 11712086. DOI: 10.14218/JCTH.2024.00238.


Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams.

Cosgrove P, Bild A, Dellinger T, Badie B, Portnow J, Nath A J Clin Med. 2025; 13(24.

PMID: 39768430 PMC: 11677125. DOI: 10.3390/jcm13247507.


References
1.
Nakamura T, Kuwai T, Kitadai Y, Sasaki T, Fan D, Coombes K . Zonal heterogeneity for gene expression in human pancreatic carcinoma. Cancer Res. 2007; 67(16):7597-604. DOI: 10.1158/0008-5472.CAN-07-0874. View

2.
Quintana E, Shackleton M, Sabel M, Fullen D, Johnson T, Morrison S . Efficient tumour formation by single human melanoma cells. Nature. 2008; 456(7222):593-8. PMC: 2597380. DOI: 10.1038/nature07567. View

3.
Cheng L, Bostwick D, Li G, Wang Q, Hu N, Vortmeyer A . Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer. 1999; 85(9):2017-22. DOI: 10.1002/(sici)1097-0142(19990501)85:9<2017::aid-cncr20>3.0.co;2-v. View

4.
Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I . Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer. 1995; 12(3):173-85. DOI: 10.1002/gcc.2870120304. View

5.
Weigelt B, Hu Z, He X, Livasy C, Carey L, Ewend M . Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 2005; 65(20):9155-8. DOI: 10.1158/0008-5472.CAN-05-2553. View